Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis

FASEB Journal

Volumn 30, Issue 12, 2016, Pages 4056-4070

  Peng, Xueyan ^a   Moore, Meagan ^a   Mathur, Aditi ^a   Zhou, Yang ^b   Sun, Huanxing ^a   Gan, Ye ^a   Herazo Maya, Jose D ^a   Kaminski, Naftali ^a   Hu, Xinyuan ^a   Pan, Hongyi ^a   Ryu, Changwan ^a   Osafo Addo, Awo ^a   Homer, Robert J ^a   Feghali Bostwick, Carol ^c   Fares, Wassim H ^a   Gulati, Mridu ^a   Hu, Buqu ^a   Lee, Chun Geun ^b   Elias, Jack A ^b   Herzog, Erica L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Idiopathic pulmonary fibrosis; Immunology; Interstitial lung disease; Scleroderma; Semaphorin 7a

Indexed keywords

BETA ACTIN; CD14 ANTIGEN; COLLAGEN; GLYCOPROTEIN P 15095; MESSENGER RNA; PLEXIN; PLEXIN C1; SYNAPTOTAGMIN; SYNAPTOTAGMIN 7; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; NERVE PROTEIN; PLXNA3 PROTEIN, MOUSE; SYT7 PROTEIN, MOUSE; VESPR SEMAPHORIN RECEPTOR; VIRUS RECEPTOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FIBROSING ALVEOLITIS; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MACROPHAGE MIGRATION; MALE; MONOCYTE; MOUSE; NONHUMAN; OXYGEN THERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERODERMA; ANIMAL; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; LUNG; LUNG FIBROSIS; MACROPHAGE; METABOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LUNG; MACROPHAGES; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PULMONARY FIBROSIS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; SYNAPTOTAGMINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85002411716     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600373R     Document Type: Article

References (47)

1. Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J. F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D.M., Johkoh, T., Kim, D. S., King, T. E., Jr., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., and Schünemann, H. J.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788-824
2. Wagner, G. R. (1997) Asbestosis and silicosis. Lancet 349, 1311-1315
3. Vanhee, D., Gosset, P., Wallaert, B., Voisin, C., and Tonnel, A. B. (1994) Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am. J. Respir. Crit. Care Med. 150, 1049-1055
4. Abid, S. H., Malhotra, V., and Perry, M. C. (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr. Opin. Oncol. 13, 242-248
5. Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., and Martinez, F. J. (2004) Mechanisms of pulmonary fibrosis. Annu. Rev. Med. 55, 395-417
6. Steen, V. D., Owens, G. R., Fino, G. J., Rodnan, G. P., and Medsger, T. A., Jr. (1985) Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum. 28, 759-767
7. Majumdar, S., Li, D., Ansari, T., Pantelidis, P., Black, C. M., Gizycki, M., du Bois, R.M., and Jeffery, P. K. (1999) Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Eur. Respir. J. 14, 251-257
8. Lewis, M. J., Lewis III, E. H., Amos, J. A., and Tsongalis, G. J. (2003) Cystic fibrosis. Am. J. Clin. Pathol. 120, S3-S13
9. King, T. E., Jr., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., Lederer, D. J., Nathan, S. D., Pereira, C. A., Sahn, S. A., Sussman, R., Swigris, J. J., and Noble, P. W.; ASCEND Study Group. (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083-2092
10. Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D.M., Inoue, Y., Kim, D. S., Kolb, M., Nicholson, A.G., Noble, P.W., Selman, M., Taniguchi, H., Brun, M., LeMaulf, F., Girard, M., Stowasser, S., Schlenker-Herceg, R., Disse, B., and Collard, H. R.; INPULSIS Trial Investigators. (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071-2082
11. Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D.E., Arriola, E., Silver, R., Strange, C., Bolster, M., Seibold, J.R., Riley, D. J., Hsu, V. M., Varga, J., Schraufnagel, D. E., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M. K., Golden, J., Olman, M., Fessler, B., Rothfield, N., and Metersky, M.; Scleroderma Lung Study Research Group. (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N. Engl. J. Med. 354, 2655-2666
12. Raghu, G., Anstrom, K. J., King, T. E., Jr., Lasky, J. A., and Martinez, F. J.; Idiopathic Pulmonary Fibrosis Clinical Research Network. (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N. Engl. J. Med. 366, 1968-1977
13. Murray, L.A., Chen, Q., Kramer, M. S., Hesson, D.P., Argentieri, R.L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., Elias, J. A., Hogaboam, C. M., and Herzog, E. L. (2011) TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. Int. J. Biochem. Cell Biol. 43, 154-162
14. Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A.T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., Hirani, N., Gauldie, J., Iredale, J. P., Sethi, T., and Forbes, S. J. (2011) Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 569-581
15. Karmouty-Quintana, H., Philip, K., Acero, L.F., Chen, N. Y., Weng, T., Molina, J.G., Luo, F., Davies, J., Le, N. B., Bunge, I., Volcik, K. A., Le, T. T., Johnston, R. A., Xia, Y., Eltzschig, H. K., and Blackburn, M. R. (2015) Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension. FASEB J. 29, 50-60
16. Blackwell, T. S., Tager, A.M., Borok, Z., Moore, B. B., Schwartz, D.A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., Brown, K.K., Chapman, H.A., Collard, H.R., Cosgrove, G. P., Deterding, R., Doyle, R., Flaherty, K. R., Garcia, C. K., Hagood, J. S., Henke, C. A., Herzog, E., Hogaboam, C.M., Horowitz, J.C., King, T. E., Jr., Loyd, J.E., Lawson, W.E., Marsh, C.B., Noble, P. W., Noth, I., Sheppard, D., Olsson, J., Ortiz, L. A., O'Riordan, T. G., Oury, T. D., Raghu, G., Roman, J., Sime, P. J., Sisson, T. H., Tschumperlin, D., Violette, S. M., Weaver, T. E., Wells, R. G., White, E. S., Kaminski, N., Martinez, F. J., Wynn, T. A., Thannickal, V. J., and Eu, J. P. (2014) Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am. J. Respir. Crit. Care Med. 189, 214-222
17. Zhu, S., Gladson, C.L., White, K.E., Ding, Q., Stewart, J., Jr., Jin, T.H., Chapman, H. A., Jr., and Olman, M. A. (2009) Urokinase receptor mediates lung fibroblast attachment andmigration toward provisional matrix proteins through interaction with multiple integrins. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L97-L108
18. Ma, B., Herzog, E. L., Lee, C. G., Peng, X., Lee, C. M., Chen, X., Rockwell, S., Koo, J. S., Kluger, H., Herbst, R. S., Sznol, M., and Elias, J.A. (2015) Role of chitinase 3-like-1 andsemaphorin7a inpulmonary melanoma metastasis. Cancer Res. 75, 487-496
19. Gan, Y., Reilkoff, R., Peng, X., Russell, T., Chen, Q., Mathai, S. K., Homer, R., Gulati, M., Siner, J., Elias, J., Bucala, R., and Herzog, E. (2011) Role of semaphorin7a signaling intransforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum. 63, 2484-2494
20. Suzuki, K., Okuno, T., Yamamoto, M., Pasterkamp, R. J., Takegahara, N., Takamatsu, H., Kitao, T., Takagi, J., Rennert, P. D., Kolodkin, A. L., Kumanogoh, A., and Kikutani, H. (2007) Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 446, 680-684
21. + regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 187, 180-188
22. Sultana, H., Neelakanta, G., Foellmer, H. G., Montgomery, R. R., Anderson, J. F., Koski, R. A., Medzhitov, R. M., and Fikrig, E. (2012) Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling. J. Immunol. 189, 3150-3158
23. Czopik, A. K., Bynoe, M. S., Palm, N., Raine, C. S., and Medzhitov, R. (2006) Semaphorin 7A is a negative regulator of T cell responses. Immunity 24, 591-600
24. Lazova, R., GouldRothberg, B.E., Rimm, D., and Scott, G. (2009) The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis. Am. J. Dermatopathol. 31, 177-181
25. Scott, G.A., McClelland, L.A., and Fricke, A. F. (2008) Semaphorin7a promotes spreading and dendricity in human melanocytes through beta1-integrins. J. Invest. Dermatol. 128, 151-161
26. Scott, G. A., McClelland, L. A., Fricke, A. F., and Fender, A. (2009) Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J. Invest. Dermatol. 129, 954-963
27. Granja, T., Köhler, D., Mirakaj, V., Nelson, E., König, K., and Rosenberger, P. (2014) Crucial role of Plexin C1 for pulmonary inflammation and survival during lung injury. Mucosal Immunol. 7, 879-891
28. Mathai, S. K., Gulati, M., Peng, X., Russell, T. R., Shaw, A. C., Rubinowitz, A. N., Murray, L. A., Siner, J. M., Antin-Ozerkis, D. E., Montgomery, R. R., Reilkoff, R. A., Bucala, R. J., and Herzog, E. L. (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Invest. 90, 812-823
29. Bauer, Y., Tedrow, J., de Bernard, S., Birker-Robaczewska, M., Gibson, K. F., Guardela, B. J., Hess, P., Klenk, A., Lindell, K. O., Poirey, S., Renault, B., Rey, M., Weber, E., Nayler, O., and Kaminski, N. (2015) A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 52, 217-231
30. Tourkina, E., Bonner, M., Oates, J., Hofbauer, A., Richard, M., Znoyko, S., Visconti, R. P., Zhang, J., Hatfield, C.M., Silver, R.M., and Hoffman, S. (2011) Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 4, 15
31. Zhou, Y., Peng, H., Sun, H., Peng, X., Tang, C., Gan, Y., Chen, X., Mathur, A., Hu, B., Slade, M. D., Montgomery, R. R., Shaw, A. C., Homer, R. J., White, E. S., Lee, C. M., Moore, M. W., Gulati, M., Lee, C.G., Elias, J.A., and Herzog, E.L. (2014) Chitinase 3-like1 suppresses injury and promotes fibroproliferative responses inmammalian lung fibrosis. Sci. Transl. Med. 6, 240ra76
32. Davies, J. Q., and Gordon, S. (2005) Isolation and culture of human macrophages. Methods Mol. Biol. 290, 105-116
33. Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., Homer, R. J., and Elias, J. A. (2004) Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J. Exp. Med. 200, 377-389
34. Chakrabarti, S., Kobayashi, K. S., Flavell, R.A., Marks, C.B., Miyake, K., Liston, D.R., Fowler, K. T., Gorelick, F. S., and Andrews, N.W. (2003) Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. J. Cell Biol. 162, 543-549
35. Kang, S., Okuno, T., Takegahara, N., Takamatsu, H., Nojima, S., Kimura, T., Yoshida, Y., Ito, D., Ohmae, S., You, D. J., Toyofuku, T., Jang, M. H., and Kumanogoh, A. (2012) Intestinal epithelial cellderived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin. J. Immunol. 188, 1108-1116
36. Hübner, R. H., Gitter, W., El Mokhtari, N. E., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., and Bewig, B. (2008) Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44, 507-511, 514-517
37. Chabbert-de Ponnat, I., Marie-Cardine, A., Pasterkamp, R. J., Schiavon, V., Tamagnone, L., Thomasset, N., Bensussan, A., and Boumsell, L. (2005) Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int. Immunol. 17, 439-447
38. Landsman, L., and Jung, S. (2007) Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol. 179, 3488-3494
39. Li, Y., Wang, P., Xu, J., Gorelick, F., Yamazaki, H., Andrews, N., and Desir, G. V. (2007) Regulation of insulin secretion and GLUT4 trafficking by the calcium sensor synaptotagmin VII. Biochem. Biophys. Res. Commun. 362, 658-664
40. Colvin, R. A., Means, T. K., Diefenbach, T. J., Moita, L. F., Friday, R.P., Sever, S., Campanella, G. S., Abrazinski, T., Manice, L. A., Moita, C., Andrews, N. W., Wu, D., Hacohen, N., and Luster, A. D. (2010) Synaptotagmin-mediated vesicle fusion regulates cell migration. Nat. Immunol. 11, 495-502
41. Vogel, D. Y., Heijnen, P. D., Breur, M., de Vries, H. E., Tool, A. T., Amor, S., and Dijkstra, C. D. (2014) Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. J. Neuroinflammation 11, 23
42. Bacaj, T., Wu, D., Yang, X., Morishita, W., Zhou, P., Xu, W., Malenka, R.C., and Südhof, T. C. (2013) Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release. Neuron 80, 947-959
43. 2+ and synaptotagmin VII-dependent delivery of lysosomal membrane to nascent phagosomes. J. Cell Biol. 174, 997-1007
44. 2+ entry and fusion pore dilation. J. Cell Sci. 127, 5218-5227
45. 2+ sensor synaptotagmin VII in macrophages and dendritic cells. Immunobiology 214, 495-505
46. 2+-sensor for synaptic vesicle replenishment. eLife 3, e01524
47. Herzog, E. L., Mathur, A., Tager, A. M., Feghali-Bostwick, C., Schneider, F., and Varga, J. (2014) Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 66, 1967-1978